Cardiovalve Ltd.
Clinical trials sponsored by Cardiovalve Ltd., explained in plain language.
-
New heart valve fix through a leg vein avoids Open-Heart surgery
Disease control OngoingThis study tests a new device called the Cardiovalve, which is threaded through a vein in the leg to fix a leaky mitral valve without open-heart surgery. It includes 30 people with severe mitral regurgitation who are too high-risk for traditional surgery. The goal is to see if th…
Phase: NA • Sponsor: Cardiovalve Ltd. • Aim: Disease control
Last updated May 26, 2026 12:11 UTC
-
New heart valve procedure for High-Risk patients halted before it began
Disease control TerminatedThis study aimed to test a new device called the Cardiovalve, which is placed through a leg vein to replace a leaky mitral heart valve without open-heart surgery. It was designed for people with severe mitral regurgitation who were considered too high-risk for traditional surgery…
Phase: NA • Sponsor: Cardiovalve Ltd. • Aim: Disease control
Last updated May 26, 2026 12:02 UTC
-
New heart valve without open surgery: hope for High-Risk patients
Disease control ENROLLING_BY_INVITATIONThis study tests a new replacement heart valve for people with severe mitral regurgitation (a leaky heart valve) who are too high-risk for open-heart surgery. The valve is delivered through a tube inserted in a leg vein, avoiding a large chest incision. The study will enroll 10 p…
Phase: NA • Sponsor: Cardiovalve Ltd. • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New valve device aims to fix leaky heart valve without open surgery
Disease control OngoingThis study tests a new device called the Cardiovalve TR system to replace a leaky tricuspid valve in the heart. About 157 people with moderate to severe leakage and symptoms like shortness of breath are taking part. The goal is to see if the device is safe and can reduce the leak…
Phase: NA • Sponsor: Cardiovalve Ltd. • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
Promising heart valve study pulled before it began
TerminatedThis study planned to test a new device called the Cardiovalve for people with severe tricuspid regurgitation (a leaky heart valve). The goal was to see if the device could safely replace the valve and reduce leakage. However, the study was withdrawn before any participants were …
Phase: NA • Sponsor: Cardiovalve Ltd.
Last updated May 15, 2026 11:55 UTC